2025 · 4th Quarter (Oct 1 - Dec 31)

REVVITY, INC.

Filed by REVVITY, INC..

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 9, 2026
Income: Not reported
Expenses: $30,000.00
Registrant: REVVITY, INC.
Client: REVVITY, INC.
Filing UUID: 05ae29d6-d98e-4eda-b74f-5f6b3ea5215a
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Diagnostic test reimbursement and policies Genomic sequencing Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs

Literal federal measure citations: HR 4709, H.R. 2810

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.